Journal Specialty Index

Cardiology

Topic	Issue
GLP-1 in Obesity and Heart Failure	FEBRUARY 2025 • VOL. 17 • NO. 1
What Clinicians Should Know About Antiplatelet Therapy for Patient With Cardiovascular Concerns	FEBRUARY 2025 • VOL. 17 • NO. 1
Symptomatic Severe Aortic Valve Regurgitation: Latest Update in Transcatheter Treatment	FEBRUARY 2025 • VOL. 17 • NO. 1
Semaglutide and Tirzepatide for Heart Failure With Preserved Ejection Fraction and Obesity	FEBRUARY 2025 • VOL. 17 • NO. 1
Statin Alternatives in the Primary Prevention of Cardiovascular Disease	MAY 2024 • VOL. 16 • NO. 5
Resistant Hypertension	MAY 2024 • VOL. 16 • NO. 5
Overview of Endovascular Treatment for Deep Vein Thrombosis Associated With May–Thurner Syndrome	MAY 2024 • VOL. 16 • NO. 5
Cardiovascular Effects of Glucocorticoids for Rheumatoid Arthritis: Friend or Foe?	AUGUST 2023 ‧ VOL. 15 ‧ NO. 6
Cardiometabolic Risks of the Sugar Substitute Erythritol	JULY 2023 ‧ VOL. 15 ‧ NO. 5
SGLT2 Inhibitors: Latest Update	JULY 2023 ‧ VOL. 15 ‧ NO. 5
Beyond Conventional Indications of ECMO	APRIL 2023 ‧ VOL. 15 ‧ NO. 2
The Expanding Pharmacological Armamentarium Against Heart Failure: Is There a Limit?	APRIL 2023 ‧ VOL. 15 ‧ NO. 2
An Update on Medical Treatment for Heart Failure With Reduced Ejection Fraction	APRIL 2023 ‧ VOL. 15 ‧ NO. 2
Diabetes and Cardiology - A Concise and Comprehensive 2022 Update for Frontline Family Doctors	JULY 2022 ‧ VOL. 14 ‧ NO. 6
Update on Glucagon-like Peptide 1 Receptor Agonists	JULY 2022 ‧ VOL. 14 ‧ NO. 6
Practical Guidance From EAS for Combination Lipid-Modifying Therapy in High-and Very-High-Risk Patients	MAY 2022 ‧ VOL. 14 ‧ NO. 4
To Harden Your Heart Makes You Feel Bad	MAY 2022 ‧ VOL. 14 ‧ NO. 4
Advances in LDL-C Management: What's Next?	MAY 2022 ‧ VOL. 14 ‧ NO. 4
Order Versus Chaos in the Elderly	FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2
Current Guidance on Management of Hypertension and the Hong Kong Perspective	FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2
What Is New for Atrial Fibrillation From the 2020 ESC Guidelines?	FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2
Advances in the Treatment of Heart Failure	FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2
Hypertensive Emergencies	FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failur	APRIL 2020 ‧ VOL. 12 ‧ NO. 4
The Management of Hyperuricaemia in Chronic Kidney Disease and Cardiovascular Disorders	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Diabetes Breakthrough Treatment for Cardiovascular Diseases and Beyond	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Learnings From a Patient Complaining of Dyspepsia	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Current Status of Transcatheter Aortic Valve Implantation (TAVI)	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Left Atrial Appendage Occlusion for Stroke Prevention: Are We Ready?	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Resistant Hypertension	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Cardiology, COVID-19 and Beyond	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Cardio-oncology - Where Breast Cancer and Cardiovascular Disease Intersect	JULY 2019 ‧ VOL. 11 ‧ NO. 5
Update on Idiopathic Pulmonary Fibrosis	MAY 2019 ‧ VOL. 11 ‧ NO. 4
Sudden Cardiac Death in Athletes and Screening for Prevention	APRIL 2019 ‧ VOL. 11 ‧ NO. 3
Food Supplements and Cholesterol/Cardiovascular Health	NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Atherosclerotic Cardiovascular Disease Events: From Stenosis to Vulnerable Plaque and Vulnerable Patient	NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Reducing LDL Cholesterol to Prevent Atherosclerotic Cardiovascular Disease	AUGUST 2018 ‧ VOL. 10 ‧ NO. 5
Coronary Artery Disease Screening in Patients with Type 2 Diabetes	APRIL 2018 ‧ VOL. 10 ‧ NO. 3
Latest Insights on the Treatment of Dyslipidemia	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Update in Chronic Heart Failure Treatment	NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7
Gastrointestinal Bleeding in Patients Treated with Novel Oral Anticoagulants: Risk and Prevention	SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6
The Important Role of Diet in the Management of Hypercholesterolemia and Prevention of Coronary Heart Disease	JULY 2016 ‧ VOL. 8 ‧ NO. 5
New Expert Opinion on the Role of Vasodilating Beta-blockers in Hypertension Management	JANUARY 2016 ‧ VOL. 8 ‧ NO. 1
Antibiotic Prophylaxis to Prevent Infective Endocarditis	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Role of Probucol in the Current Treatment of Atherosclerosis and Vascular Disease	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Probucol: Reappraisal of an Old Drug for Atherosclerosis	MAY 2015 ‧ VOL. 7 ‧ NO. 3
Latest Update on Hypertension Guidelines: Combination Therapy and More	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6
An Update on Transcatheter Aortic Valve Implantation	SEPTEMBER 2014 ‧ VOL. 6 ‧ NO. 5
An Update in the Management of Atrial Fibrillation	JULY 2014 ‧ VOL. 6 ‧ NO. 4
Update on the Use of Angiotensin Receptor Blockers in Hypertension: A Focus on Azilsartan Medoxomil	JUNE 2014 ‧ VOL. 6 ‧ NO. 3
Updates on Management of Coronary Artery Disease	DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Blood Pressure Variability: Is It Important and How Can We Assess It?	DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Cardiovascular Risk Factors, Morbidity and Mortality in Psoriasis	NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6
Heart Rate Reduction as a Goal in the Management of Cardiovascular Risk	MARCH 2013 ‧ VOL. 5 ‧ NO. 2
Advances in the Management of Coronary Artery Disease	DECEMBER 2012 ‧ VOL. 4 ‧ No. 7
Contemporary Guidelines on Cardiovascular Disease Prevention and Updated Recommendations on the Use of Antithrombotics	SEPTEMBER 2012 ‧ VOL. 4 ‧ NO. 5
Primary Prevention of Sudden Cardiac Death	MAY 2012 ‧ VOL. 4 ‧ NO. 3
Hypertension and Atrial Fibrillation	MAY 2012 ‧ VOL. 4 ‧ NO. 3
The Role of Combination Therapy in the Management of Hypertension	MAY 2012 ‧ VOL. 4 ‧ NO. 3
Cardiovascular Risk in Patients With Psoriatic Arthritis	JANUARY 2012 ‧ VOL. 4 ‧ NO. 1
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part II: Gastrointestinal Bleeding Induced by Clopidogrel or Dual Antiplatelet Therapy	JANUARY 2012 ‧ VOL. 4 ‧ NO. 1
Managing Atrial Fibrillation to Reduce Mortality and Morbidity	DECEMBER 2011 ‧ VOL. 3 ‧ NO. 7
Niacin for the Treatment of Dyslipidaemia and Atherosclerosis	JULY 2011 ‧ VOL. 3 ‧ NO. 4
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part I: Gastrointestinal Bleeding Induced by Low-dose Aspirin	MARCH 2011 ‧ VOL. 3 ‧ NO. 2
Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction	MARCH 2011 ‧ VOL. 3 ‧ NO. 2
Treatment of Left Main Disease in 2011	JANUARY 2011 ‧ VOL. 3 ‧ NO. 1
Angiotensin Receptor Blockers - Across the Cardiovascular Continuum	DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8
Case Study: A 75-year-old Gentleman With Recurrent Palpitation	SEPTEMBER 2010 ‧ VOL. 2 ‧ NO. 6
Sleep Apnoea and Arrthymias	MARCH 2010 ‧ VOL. 2 ‧ NO. 2
Coronary Artery Disease: Pills, Stents or Surgeon's Knife?	DECEMBER 2009 ‧ VOL. 1 ‧ NO. 6
The Post-cardiac Arrest Syndrome	JULY 2009 ‧ VOL. 1 ‧ NO. 3
Update on Management of Heart Failure	JANUARY 2009 ‧ VOL. 1 ‧ NO. 1
Approaches to Carotid Stenosis	JANUARY 2009 ‧ VOL. 1 ‧ NO. 1
Utilizing Cardiac CT for the Detection of Coronary Artery Disease	JANUARY 2009 ‧ VOL. 1 ‧ NO. 1
Heart Disease Does not Equate Coronary Artery Disease	JANUARY 2009 ‧ VOL. 1 ‧ NO. 1